Table 1.
Baseline sociodemographic and clinical characteristics of the total sample (n=273)
| Women [n (%)] | 160 (58.2) |
| Age [mean (SD)] (years) | 44.1 (7.9) |
| Smoking [n (%)] | 76 (27.8) |
| Heavy alcohol consumption [n (%)] | 39 (14.3) |
| Blood pressure [mean (SD)] (mmHg) | |
| Systolic | 142.7 (15.3) |
| Diastolic | 89.3 (9.6) |
| Obesity [n (%)] (BMI ≥ 30 kg/m2) | 168 (61.5) |
| Dyslipidemia [n (%)] | 127 (46.5) |
| Patients with antihypertensive treatment [n (%)] | 173 (63.3) |
| Diuretics | 80 (29.1) |
| Beta blockers | 54 (19.6) |
| Angiotensin-converting-enzyme inhibitors | 54 (19.6) |
| Calcium channel antagonists | 46 (16.7) |
| Baseline electrocardiographic ST-T changes and left ventricular hypertrophy* [n (%)]: | |
| Major ST (MC 9–2; 4–1; 4–2) | 15 (5.5) |
| Inverse Major T wave (MC 5–1; 5–2) | 6 (2.2) |
| Inverse Minor T wave (MC 5–3) | 16 (5.9) |
| Minor ST (MC 4–3) | 5 (1.8) |
| Left ventricular hypertrophy (Cornell criteria) | 24 (8.7) |
SD: standard deviation; BMI: body mass index; A-V: atrioventricular; MC: Minessota code.
*A total of 52 patients had 66 basal electrocardiographic abnormalities.